Oculis' main value driver appears to be OCS-01, which targets a respectable $4B DME TAM with its non-invasive eye drops. See ...

The global vision care products market is projected to reach USD 103.7 billion by 2032, growing at a CAGR of 6.21%. This growth ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Fort Worth, Texas-based Alcon Laboratories has voluntarily recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, which are packaged in batches of 25.

Young nearsighted kids who wear bifocal contact lenses that slow uncoordinated eye growth do not lose the benefits of the treatment once they stop wearing the lenses, new research shows.

We recently compiled a list of the Best Medical Stocks To Buy Under $20. In this article, we are going to take a look at ...

"My patients appreciate being able to recycle their used eye health materials." Healthcare company keeps over 450,000 pounds ...

City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration ...

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

Pre-tax losses at the main Irish unit of eye care product firm, Bausch + Lomb increased by 4.5% to $959.7m (€925m) in 2023.